Autoantibodies against RTN4A have been found in serum and cerebrospinal fluid of patients with MS, especially in those with relapsing-remitting rather than chronic progressive MS (Reindl et al. 2003). This evidence concerns the gene RTN4 and myeloid sarcoma.